Downregulation of FBLN1 expression has been shown to be associated with tumour progression and act as a prognostic factor in many cancers such as gastric, renal cell carcinoma, hepatocellular carcinoma and lung adenocarcinoma [45,46,47,48]. The gene discussed is FBLN1; the disease is hepatocellular carcinoma.